A comparison between acyclovir and trifluorothymidine ophthalmic ointment in the treatment of epithelial dendritic keratitis. A double blind, randomized parallel group trial

Acta Ophthalmol (Copenh). 1989 Feb;67(1):51-4. doi: 10.1111/j.1755-3768.1989.tb00722.x.

Abstract

This report presents the results of a double blind randomized study comprising 50 patients with epithelial herpes simplex keratitis. Twenty-five patients received 3% acyclovir ophthalmic ointment, the other 25 patients 2% trifluorothymidine (TFT) ophthalmic ointment. The mean duration of treatment in the 2 study groups before healing of the epithelial ulceration was obtained was 6.7 days and 5.9 days, respectively (no statistically significant difference). Two patient (8%) in the acyclovir group and 1 patient (4%) in the TFT group failed to heal within 14 days of treatment. No clinically significant adverse effects were recorded.

Publication types

  • Clinical Trial
  • Comparative Study
  • Randomized Controlled Trial

MeSH terms

  • Acyclovir / administration & dosage*
  • Adolescent
  • Adult
  • Aged
  • Clinical Trials as Topic
  • Double-Blind Method
  • Female
  • Humans
  • Keratitis, Dendritic / drug therapy*
  • Male
  • Middle Aged
  • Ointments
  • Ophthalmic Solutions
  • Random Allocation
  • Trifluridine / administration & dosage

Substances

  • Ointments
  • Ophthalmic Solutions
  • Trifluridine
  • Acyclovir